Comprehensive diagnosis of tumor involves multiple staining methods to detect functional and structural proteins present in the cells of tissue samples extracted from the patient suffering from a tumor-related ailment. This method enhances the process of delineating stages of the disease and gaining relative information from the microenvironment of a tumor. Biomarkers on the other hand act as health indicators that help tracking and measuring a specific biological condition of a patient. This biological condition or characteristic is further analyzed and evaluated by clinicians to discover patient pharmacological responses to medical administrations.
Identifying the exact location of a tumor requires a special tool called multiplex biomarker imaging which also determines the status (oxy or deoxy form) of hemoglobin, helps detect potential targetable surface markers, discovers the presence of apoptosis and documents drug delivery. Advantages like reduced costs for research and testing, advanced evaluation of thousands of tissues in a single attempt, and the rising demand for clinical diagnostics due to the growing prevalence of chronic diseases, are important factors driving the global multiplex biomarker imaging market.
Identifying the exact location of a tumor requires a special tool called multiplex biomarker imaging which also determines the status (oxy or deoxy form) of hemoglobin, helps detect potential targetable surface markers, discovers the presence of apoptosis and documents drug delivery. Advantages like reduced costs for research and testing, advanced evaluation of thousands of tissues in a single attempt, and the rising demand for clinical diagnostics due to the growing prevalence of chronic diseases, are important factors driving the global multiplex biomarker imaging market.
 |
| Global Multiplex Biomarker Imaging Market |
The biomarker imaging techniques are useful in monitoring cancer and related diagnostics. The rising incidence of cancer is pushing governments to increase funds for research and development in the biomarker imaging domain. Increase in production of multispectral imaging devices that are used for multiplexing is further expected to increase global multiplex biomarker imaging market size. The manufacturers of this system realize the limitation of previous imaging concepts like flow cytometry and serial processes and are generously investing in the far more advanced technologies of multiplex biomarker imaging which provide deep clinical insight on the anatomy of an intact tumor.
Latest innovations like the powerful multiplex immunohistochemistry (mIHC) are gaining popularity as it provides advanced information into the heterogeneity of a disease and the characterization of patient’s biology mechanisms. Presently, many new standardized software packages specialized in analyzing automated tissue cell segmentation and phenotyping raises the credibility of the discoveries made through research. Market restraints like the complexity of procedures, ethical issues, and stringent government policies hinder market growth. Multiplex biomarker imaging devices are mainly used for cancer research in academic institutes and translation laboratories, which creates impediments for profit generation of the imaging system manufacturers.
North America is expected to dominate the regional segment with the highest market share in the foreseeable future. The global multiplex biomarker imaging market is projected to witness significant demand for prominent diagnostic reagents.
Latest innovations like the powerful multiplex immunohistochemistry (mIHC) are gaining popularity as it provides advanced information into the heterogeneity of a disease and the characterization of patient’s biology mechanisms. Presently, many new standardized software packages specialized in analyzing automated tissue cell segmentation and phenotyping raises the credibility of the discoveries made through research. Market restraints like the complexity of procedures, ethical issues, and stringent government policies hinder market growth. Multiplex biomarker imaging devices are mainly used for cancer research in academic institutes and translation laboratories, which creates impediments for profit generation of the imaging system manufacturers.
North America is expected to dominate the regional segment with the highest market share in the foreseeable future. The global multiplex biomarker imaging market is projected to witness significant demand for prominent diagnostic reagents.
Our Related Blog:
No comments:
Post a Comment